Vitex (Chasteberry) for PMS: Benefits, Evidence, Dosing, and Safety
Does Vitex Help Premenstrual Syndrome?
Premenstrual syndrome (PMS) encompasses mood swings, irritability, anxiety, fatigue, breast tenderness, headaches, and bloating. Vitex agnus-castus (chasteberry) has been used for centuries for female reproductive complaints. Its diterpenoids and flavonoids appear to modulate pituitary hormone secretion—reducing prolactin, normalizing luteal-phase progesterone, and balancing estrogen/progesterone ratios.
Scientific Evidence
- A 2012 Cochrane review found Vitex superior to placebo for global PMS symptoms, but noted small, heterogeneous, low-quality trials.
- A 2017 systematic review (13 RCTs) reported significant improvement in PMS symptoms (irritability, mood, breast pain, bloating) with Vitex vs. placebo; effect size moderate.
- Comparative trials: Vitex similar to fluoxetine for PMDD mood symptoms; inferior to combined OCP for physical symptoms.
- Bottom line: Promising but not definitive. More large, high-quality RCTs needed. Generally well-tolerated.
Dosing and Administration
- Typical dose: 250–500 mg daily of standardized extract (0.5–1.0% agnuside/casticin), once or twice daily.
- Forms: Capsules, tablets, liquid extract, tea.
- Timing: Can be taken throughout cycle or luteal phase only; continuous use often preferred.
- Onset: May take 2–3 menstrual cycles for full effect. If no improvement after 3 months, reassess.
Side Effects and Interactions
- Common (mild): Nausea, GI upset, headache, dizziness, acne, menstrual flow changes.
- Rare: Allergic reactions.
- Key interactions:
- Hormonal contraceptives: Vitex may reduce efficacy (dopaminergic/prolactin effects).
- Dopamine agonists/antagonists (e.g., metoclopramide, antipsychotics): theoretical interaction.
- Hormone replacement therapy.
- Fertility medications.
Contraindications
- Pregnancy and breastfeeding (insufficient safety data; hormonal effects).
- Hormone-sensitive conditions (breast/ovarian/uterine cancer, endometriosis, uterine fibroids)—theoretical risk.
- Pituitary disorders.
- Concurrent dopamine-related medications.
Conclusion
Vitex shows promise for PMS/PMDD with a favorable safety profile for most women. It is not a substitute for medical evaluation of severe symptoms. Consult your healthcare provider before starting, especially if on hormonal medications or with hormone-sensitive conditions.
Genetic Disorders - Related Articles
- Stem Cell Therapy for SCID: Early Diagnosis and Lifesaving Transplants
- Radial Aplasia-Thrombocytopenia Syndrome (TAR) - Symptoms, Causes & Treatment
- Conjoined Twins: Gender Prevalence and Incidence
- Understanding Chromosomal Aberrations in Down Syndrome: Trisomy 21 & Translocation
- How Down Syndrome Occurs: Nondisjunction, Translocation, and Mosaicism Explained
- Recombinant DNA: Applications & Natural Examples
- P53: The Guardian of the Genome - Functions, Discovery & Role in Cancer
